BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
BillionToOne, Inc.NASDAQ: BLLN
Selling, General & Admin · Q2 FY2026 · quarter ended Jun 2026
Selling, general & admin growth accelerates
Q2 FY2026 selling, general & admin of $54.29M rose 62.8% year over year, ahead of the +60.0% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 16.6% from the prior quarter.
Context
- Selling, general & admin amounted to 46.9% of revenue in FY2025, down 13.1 pp from a year earlier.
- Selling, general & admin increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 5 analysts of $299.94M (+109.7%) for the fiscal year ending Dec 2026, a step up from the +56.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $54.29M+16.6% QoQ
- Last fiscal yearDec 2025
- $143.05M+56.4% YoY
- LTMJun 2026
- $180.71M+60.0% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 143.05M USD
- Year-over-year change
- +56.4%
- 2-year CAGR
- +49.1%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 143.05M | +56.4% |
| FY2024 | 2024-12-31 | 91.47M | +42.1% |
| FY2023 | 2023-12-31 | 64.39M | — |
Selling, General & Admin vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's LTM Jun 2026 selling, general & admin of $180.71M is the 8th highest of the 9 companies compared; the peer median is $325.68M.
- Its year-over-year change of +60.0% is the highest of 9, against a peer median of +11.4%.
- Selling, general & admin amounts to 45.5% of revenue for BLLN, versus a peer median of 58.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.25B | +22.3% | +26.0% | 46.4% | |
| LTM Sep 2026 | $951.07M | +44.5% | +15.0% | 74.4% | |
| LTM Mar 2026 | $537.7M | -3.2% | +1.5% | 64.9% | |
| LTM Jun 2026 | $359.09M | +0.6% | +9.5% | 46.9% | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | $292.26M | +58.0% | -10.9% | 64.3% |
| LTM Jun 2026 | $291.09M | -3.7% | -2.4% | 176.1% | |
| LTM Jun 2026 | $201.58M | -7.5% | +6.6% | 35.9% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $180.71M | +60.0% | — | 45.5% |
| LTM Mar 2026 | $166.18M | +30.2% | +2.2% | 51.9% | |
| Peer median (excluding BLLN) | $325.68M | +11.4% | +4.4% | 58.1% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 71.73M | 152.58M | 305.11M |
| Cost of Revenue | 54.42M | 71.67M | 96.65M |
| Gross Profit | 17.31M | 80.92M | 208.46M |
| Gross Margin | 24.1% | 53.0% | 68.3% |
| Research & Development | 22.41M | 36.6M | 49.38M |
| Selling, General & Admin | 64.39M | 91.47M | 143.05M |
| Operating Expenses | 86.8M | 128.06M | 192.44M |
| Depreciation & Amortization | 6.46M | 11.69M | 11.91M |
| EBITDA | (72.94M) | (27.47M) | 19.76M |
| EBITDA Margin | -101.7% | -18.0% | 6.5% |
| Operating Income | (69.5M) | (47.15M) | 16.02M |
| Operating Margin | -96.9% | -30.9% | 5.3% |
| Interest Income | 3.46M | 5.82M | 7.75M |
| Interest Expense | 3.27M | 2.39M | 95K |
| Other Income / Expenses | (13.18M) | 5.61M | (8.26M) |
| Income Before Tax | (82.67M) | (41.54M) | 7.76M |
| Pre-Tax Margin | -115.3% | -27.2% | 2.5% |
| Income Tax Expense | 9K | 29K | 305K |
| Net Income | (82.68M) | (41.57M) | 7.45M |
| Net Margin | -115.3% | -27.2% | 2.4% |
| EPS (Basic) | (1.85) | (0.93) | 0.06 |
| EPS (Diluted) | (1.85) | (0.93) | 0.06 |
| Weighted Avg Shares | 44.72M | 44.72M | 45.8M |
| Weighted Avg Shares (Diluted) | 44.72M | 44.72M | 45.8M |
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.